Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Igor Helbrecht"'
Autor:
Igor Helbrecht, Daniel Heiter, Weiwei Yang, Tamas Vincze, Andrew Hanneman, Thomas Lutz, Laurence Ettwiller, Matthias Bochtler, Shuang-yong Xu
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Winged helix (wH) domains, also termed winged helix-turn-helix (wHTH) domains, are widespread in all kingdoms of life and have diverse roles. In the context of DNA binding and DNA modification sensing, some eukaryotic wH domains are known as sensors
Externí odkaz:
https://doaj.org/article/c1bfdaf07b4c428e872de0fa5e3e2734
Autor:
Mohammed I Khan, Anna M Czarnecka, Sławomir Lewicki, Igor Helbrecht, Klaudia Brodaczewska, Irena Koch, Robert Zdanowski, Magdalena Król, Cezary Szczylik
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165718 (2016)
Recent advancement in cancer research has shown that tumors are highly heterogeneous, and multiple phenotypically different cell populations are found in a single tumor. Cancer development and tumor growth are driven by specific types of cells-stem c
Externí odkaz:
https://doaj.org/article/40c15b1b99104db09b4622a82ef93273
Autor:
Michal Fiedorowicz, Pawel Golik, Cezary Szczylik, Damian Matak, Igor Helbrecht, Anna M. Czarnecka, Ewa Bartnik, Łukasz Szymański
Publikováno v:
Postępy Biochemii. 65:95-102
Raki stanowią 85% guzów nerki. W Polsce każdego roku raka nerki rozpoznaje się u prawie czterech tysięcy osób, a ponad dwa tysiące z nich umiera. Znanych jest kilka rodzajów raka nerki, spośród których najczęściej występującym jest rak
Autor:
Igor Helbrecht, Thomas Lutz, Michal Pastor, Shuang-yong Xu, Honorata Czapinska, Katarzyna Krakowska, Matthias Bochtler
Publikováno v:
Nucleic acids research 49(3), 1708-1723 (2021). doi:10.1093/nar/gkaa1218
Nucleic Acids Research
Nucleic Acids Research
Nucleic acids research / Special publication 49(3), 1708 – 1723 (2021). doi:10.1093/nar/gkaa1218
Many modification-dependent restriction endonucleases (MDREs) are fusions of a PUA superfamily modification sensor domain and a nuclease catalytic
Many modification-dependent restriction endonucleases (MDREs) are fusions of a PUA superfamily modification sensor domain and a nuclease catalytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fecc96a7a236760060b0fa1aac00d5d
https://bib-pubdb1.desy.de/record/454417
https://bib-pubdb1.desy.de/record/454417
Autor:
Łukasz, Szymanski, Igor, Helbrecht, Michał, Fiedorowicz, Damian, Matak, Ewa, Bartnik, Paweł, Golik, Cezary, Szczylik, Anna M, Czarnecka
Publikováno v:
Postepy biochemii. 65(2)
Cancers account for 85% of renal tumors. In Poland renal cancer is diagnosed in almost four thousands patients every year and two thousands of them dies. The most common subtype of renal cancer is clear cell renal cell carcinoma (ccRCC), which accoun
Autor:
Magdalena Król, Cezary Szczylik, Igor Helbrecht, Anna M. Czarnecka, Irena Koch, Klaudia Brodaczewska, Mohammed Imran Khan, Sławomir Lewicki, Robert Zdanowski
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165718 (2016)
PLoS ONE
PLoS ONE
Background Recent advancement in cancer research has shown that tumors are highly heterogeneous, and multiple phenotypically different cell populations are found in a single tumor. Cancer development and tumor growth are driven by specific types of c
Autor:
Magdalena Król, Igor Helbrecht, Sławomir Lewicki, Mohammed Imran Khan, Robert Zdanowski, Cezary Szczylik, Anna M. Czarnecka
Publikováno v:
Journal of Clinical Oncology. 34:e16091-e16091
e16091Background: Tumor initiating cells represent a minor cell subpopulation that is resistant to therapies and has cancer stem cell characteristics including self-renewal, multiple lineage differ...
Autor:
Mohammed Imran Khan, Ewa Bartnik, Igor Helbrecht, Cezary Szczylik, Anna M. Czarnecka, Fei Lian
Publikováno v:
Stem Cell Research & Therapy
In recent years, cancer stem cells (CSCs)/tumor initiating cells (TICs) have been identified inside different tumors. However, currently used anti-cancer therapies are mostly directed against somatic tumor cells without targeting CSCs/TICs. CSCs/TICs